Dr. Jose Francisco Leis, MD

Dr. Leis practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Dr. Leis' NPI, 1790793271, was assigned on August 3, 2006. Dr. Leis graduated from College of Medicine - Tucson in 1986. Dr. Leis holds Arizona license 36501.

Dr. Leis' primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Dr. Leis' primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Leis to 1 more ambulatory surgery center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leis practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Leis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Leis is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Leis' licenses on file in 2 states: Arizona and Oregon.

Dmand AI lists chronic leukemia, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Leis treats.

CMS data shows 19,200 Medicare services from Dr. Leis across 29 procedure codes in 2024, for 479 Medicare patients. Medicare paid $585,074 for them.

CMS counts 479 Medicare patients who saw Dr. Leis in 2024. The largest group is 65 to 74, with 229 patients. 74% of them have high cholesterol, and 67% have high blood pressure. 3% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leis' median patient age at 73, with 45% women.

In 2024, Dr. Leis wrote 555 Medicare Part D claims for 78 patients. 58% of them were for generic drugs. CMS names the drug for 436 of them, across 13 drugs with 11 or more claims each, at $2,900,977 in total drug cost. In 2023, CMS named 456 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Leis for performance year 2024, reported as part of a group. Dr. Leis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 145 papers to Dr. Leis, published from 2005 to 2024. 2020 was the busiest year, with 14. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Combined Chemotherapy Protocols and Hematopoietic Stem Cell Transplantation. Dr. Leis has published most often in Leuk Lymphoma. Dr. Leis' most frequent co-authors are Timothy George Call, MD, Sameer Ashok Parikh, MD and Wei Ding, MD.

Dmand AI links Dr. Leis to 11 clinical trials, 6 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Hematologic Neoplasms. Mayo Clinic sponsors the most, 7.

CMS Open Payments shows 7 general payments to Dr. Leis from 5 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 76% of the total. Jazz Pharmaceuticals Inc. paid the most, $218.

Dmand AI lists 5 awards for Dr. Leis, most recently Press Ganey Top Provider Recognition Award in 2020.

Dr. Leis graduated from College of Medicine - Tucson in 1986. Dr. Leis is a member of American Society for Blood and Marrow Transplantation, ASCO, ASH and European Society of Hematology.

Dr. Leis is in network with 4 carriers, including United Healthcare, Excellus BlueCross BlueShield and Blue Cross and Blue Shield of Kansas City. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.